Maria Potgieter

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

Gert Ulrich Kuerzel, U. Shukla, H. E. Scholtz et al. · Current Medical Research and Opinion · 2003 · 129 citations

Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment

Luís Almeida, Johané Potgieter, Joana Maia et al. · European Journal of Clinical Pharmacology · 2007 · 96 citations

Hepatology, Liver Physiology, Pharmacology +6

Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate

Joana Maia, Luís Almeida, Amílcar Falcão et al. · International Journal of Clinical Pharmacology and Therapeutics · 2008 · 81 citations

Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusion

H. E. Scholtz, S. G. Pretorius, D. H. Wessels et al. · Acta Diabetologica · 2003 · 26 citations

Diabetes Management, Healthy Subjects, Medicine +9

Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus.

Matthias Herz, Vipin Arora, Barbara N. Campaigne et al. · PubMed · 2003 · 21 citations